Pharma Mar (OTCMKTS:PHMMF – Get Free Report)’s share price traded up 4.6% on Friday . The company traded as high as $90.21 and last traded at $90.21. 174 shares changed hands during mid-day trading, an increase of 1,844% from the average session volume of 9 shares. The stock had previously closed at $86.26.
Pharma Mar Stock Up 4.6%
The company has a quick ratio of 2.25, a current ratio of 2.84 and a debt-to-equity ratio of 0.19. The company has a 50 day moving average of $87.28 and a two-hundred day moving average of $92.78.
About Pharma Mar
PharmaMar is a Spain-based biopharmaceutical company that specializes in the discovery and development of novel oncology therapies derived from marine organisms. Founded in 1986 as part of Grupo Zeltia, the company has pioneered the use of compounds extracted from deep-sea organisms to create synthetic analogs aimed at treating various forms of cancer. Its core expertise lies in marine biotechnology, medicinal chemistry and oncology-focused clinical development.
The company’s flagship product is Yondelis (trabectedin), an antitumor agent approved in the European Union for the treatment of soft tissue sarcoma and relapsed platinum-sensitive ovarian cancer.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
